Table 1.
Demographic and clinical characteristics of the PTSD and healthy control participants
Characteristic | PTSD (n = 10) | Control (n = 10) |
---|---|---|
Age (years) | 44.7 ± 11.36 | 44.4 ± 11.08 |
Education (years) | 14.4 ± 2.4 | 15 ± 2.9 |
Sex (female) | 5 (50%) | 5 (50%) |
CAPS—total | 38.4 ± 10.45 | |
CAPS—intrusion | 8.4 ± 0.95 | |
CAPS—hyperarousal | 11.8 ± 1.11 | |
CAPS—avoidance | 5.4 ± 0.48 | |
Medications | ||
Clonidine | 2 | |
Prazosin | 2 | |
Propranolol | 1 | |
Sertraline | 1 | |
Desvenlafaxine | 1 | |
Escitalopram | 1 | |
Amitriptyline | 2 | |
Venlafaxine | 1 |
Mean ± SD or N (%)
CAPS Clinician administered PTSD scale